Response to Trimethoprim-Sulfamethoxazole in a Pediatric Hematopoietic Stem Cell Transplant Recipient With Disseminated Toxoplasmosis: A Case Report. (6th March 2021)

• Record Type: Journal Article
• Authors: Khan, Aslam; Schwenk, Hayden T; Kohlman, Krystal; Bertaina, Alice; Cho, Stephanie; Montoya, Jose G; Contopoulos-Ioannidis, Despina
• Is Part Of: Journal of the Pediatric Infectious Diseases Society. Volume 10:Number 6(2021)
• Page Start: 745
• Page End: 748
• Publication Date: 2021-03-06
• Subjects: bone marrow transplant -- hematopoietic -- stem cell transplant -- TMP-SMX -- toxoplasma -- trimethoprim-sulfamethoxazole; Communicable diseases in children -- Periodicals; Children -- Diseases -- Periodicals; 618.929
• DOI: 10.1093/jpids/piab006
• Languages: English
• ISSNs: 2048-7193

Abstract

Abstract: We describe the presentation and treatment of a patient who developed ongoing fever and diagnosed with disseminated toxoplasmosis post-hematopoietic stem cell transplantation. He was initially treated with trimethoprim-sulfamethoxazole (TMP-SMX) and there was dramatic improvement in his fever curve. He successfully completed a modified course of therapy.